adenocarcinoma
Showing 1 - 25 of 170
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Recruiting
- Adenocarcinoma
- +2 more
- collection of biological samples
-
Bordeaux, France
- +7 more
Nov 20, 2023
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
Ethmoid Sinus Tumor, Adenocarcinoma, Circulating Tumor Cell Trial (Liquid biopsy)
Not yet recruiting
- Ethmoid Sinus Tumor
- +2 more
- Liquid biopsy
- (no location specified)
Oct 18, 2023
Prostatic Tumor, Adenocarcinoma, Tumor Recurrence Trial in Rennes, Pointe-à-Pitre (Standard care)
Recruiting
- Prostatic Neoplasm
- +3 more
- Standard care
-
Rennes, Ille-et-Vilaine, France
- +1 more
Sep 14, 2023
Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma Trial in Houston (TROP2-CAR-NK, Cyclophosphamide, Fludarabine)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- TROP2-CAR-NK
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 27, 2023
HER2-positive Locally Advanced/Metastatic Gastric and/or
Not yet recruiting
- Adenocarcinoma
-
Arkhangelsk, Russian Federation
- +40 more
May 29, 2023
Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in
Not yet recruiting
- Head and Neck Cancer
- +8 more
- Tumor and HLA Profiling
- (no location specified)
Mar 31, 2023
Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound
Recruiting
- Hilar Cholangiocarcinoma
- +4 more
- Endoscopic Ultrasound registration
-
Rotterdam, Zuid-Holland, NetherlandsErasmus University Medical Center
Jan 11, 2023
Sputum DNA Testing for Lung Cancer in China
Recruiting
- Lung Cancer
- +15 more
- Diagnostic Test: Sputum DNA methylation analysis
- chest CT or pathological examination
-
Guangzhou, Guangdong, ChinaNanfang Hospital of Southern Medccal University
Dec 29, 2022
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma Trial in France, Italy, Spain (Standard treatment: Control arm,
Not yet recruiting
- Cervical Carcinoma
- +2 more
- Standard treatment: Control arm
- Experimental arm
-
Bordeaux, France
- +18 more
Oct 12, 2022
Tumor, Adenocarcinoma Trial in Houston (Pembrolizumab, lenvatinib)
Recruiting
- Tumor
- Adenocarcinoma
-
Houston, TexasM D Anderson Cancer Center
Oct 13, 2022
Prostate Cancer, Adenocarcinoma, Prostatic Tumors Trial (bpMRI, Image-Fusion targeted and systematic Biopsy)
Not yet recruiting
- Prostate Cancer
- +4 more
- bpMRI
- Image-Fusion targeted and systematic Biopsy
- (no location specified)
Oct 7, 2022
Resectable or Locally Advanced Borderline Pancreatic
Active, not recruiting
- Pancreas Cancer
- Adenocarcinoma
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Aug 19, 2022
Subjects Previously Enrolled on NCI Surgery Branch Studies
Enrolling by invitation
- Melanoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Metastatic Cancer, Carcinoma, Adenocarcinoma Trial in Cleveland (18F-Clofarabine)
Recruiting
- Metastatic Cancer
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 11, 2022